Defining and recognising locally advanced basal cell carcinoma

Archive ouverte

Amici, J. M. | Battistella, M. | Beylot-Barry, M. | Chatellier, A. | Dalac-Ra, S. | Dreno, B. | Falandry, Claire | Froget, N. | Giacchero, D. | Grob, J. J. | Guerreschir, P. | Leccia, M. T. | Malard, O. | Mortier, L. | Routier, E. | Stefan, A. | Stefan, D. | Stoebner, P. E. | Basset-Seguin, N.

Edité par CCSD ; John Libbey Eurotext -

International audience. Rarely, basal cell carcinomas (BCCs) have the potential to become extensively invasive and destructive, a phenomenon that has led to the term "locally advanced BCC" (laBCC). We identified and described the diverse settings that could be considered "locally advanced". The panel of experts included oncodermatologists, dermatological and maxillofacial surgeons, pathologists, radiotherapists and geriatricians. During a 1-day workshop session, an interactive flow/sequence of questions and inputs was debated. Discussion of nine cases permitted us to approach consensus concerning what constitutes laBCC. The expert panel retained three major components for the complete assessment of laBCC cases: factors of complexity related to the tumour itself, factors related to the operability and the technical procedure, and factors related to the patient. Competing risks of death should be precisely identified. To ensure homogeneous multidisciplinary team (MDT) decisions in different clinical settings, the panel aimed to develop a practical tool based on the three components. The grid presented is not a definitive tool, but rather, it is a method for analysing the complexity of laBCC.

Consulter en ligne

Suggestions

Du même auteur

Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part

Archive ouverte | Frouin, E. | CCSD

International audience. Introduction. - CARADERM is a French national network that includes patients with rare skin adnexal neoplasms. The present paper describes only the adnexal neoplasm part of this network. The ...

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size

Archive ouverte | Dazard, J. E. | CCSD

International audience. p53 transcription factor is mutated in most skin cell carcinomas and in more than 50% of all human malignancies. One of its transcriptional targets is MDM2, which in turn down-regulates p53. ...

Effects of high doses of ionising radiation on bone in rats: A new model for evaluation of bone engineering

Archive ouverte | Lerouxel, E. | CCSD

International audience. The purpose of this study was to assess the effects of high doses of ionising radiation on the histology and healing of bone in an experimental model of 12 inbred rats. Ten of the rats had ex...

Chargement des enrichissements...